Merrobe 1g Injection contains Meropenem 1000 mg, a broad-spectrum carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria. It is indicated for the treatment of severe bacterial infections including complicated intra-abdominal infections, bacterial meningitis, complicated skin and soft tissue infections, and complicated urinary tract infections. Meropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. The injection is administered intravenously, ensuring rapid systemic distribution and optimal therapeutic concentrations. Merrobe 1g Injection is particularly useful in hospital settings for critically ill patients or those with infections caused by multidrug-resistant organisms. Dosage and duration of therapy should be determined based on the severity of infection, renal function, and susceptibility of the causative pathogens. Caution is advised in patients with a history of hypersensitivity to beta-lactam antibiotics. Common adverse effects may include gastrointestinal disturbances, rash, and transient elevations in liver enzymes. It is essential to monitor renal function during prolonged therapy. Merrobe 1g Injection should be used under strict medical supervision to ensure efficacy and minimize the risk of resistance development.